Gardnerella vaginalis is a Gram-variable anaerobic bacterium present in 100 % of women with bacterial vaginosis (BV). BV is a complex polymicrobial condition with no single causative agent. The current laboratory detection method for BV relies on a Gram-stain Nugent score to estimate the quantity of different bacterial morphotypes in the vaginal micro flora. Whilst the Nugent score can distinguish between women with and without BV, a significant proportion are categorized as intermediate, which fails to differentiate a normal from an abnormal vaginal micro flora. A singleplex G. vaginalis TaqMan real-time quantitative PCR (qPCR) assay was developed and compared with the 'gold standard' Nugent score. Detection and quantification of G. vaginalis was performed on vaginal specimens with positive, negative and intermediate Nugent scores. The G. vaginalis qPCR assay demonstrated high analytical specificity against a broad microbial panel and analytical sensitivity down to 3.1610 4 copies ml
INTRODUCTION
Gardnerella vaginalis is a facultative Gram-variable anaerobic bacterium belonging to the family Bifidobacteriaceae and is the dominant species involved in bacterial vaginosis (BV). Although BV is a polymicrobial condition with no single causative agent, 100 % of women with BV are colonized with G. vaginalis. G. vaginalis is also a normal commensal of the vaginal micro flora in healthy women, so its role in BV is likely to be complex (Patterson et al., 2010; Yeoman et al., 2010; Zozaya-Hinchliffe et al., 2010) . The typical presentation of BV involves alteration of the normal vaginal micro flora, where a reduction in vaginal Lactobacillus spp. and an overgrowth of anaerobic bacteria, predominantly G. vaginalis, occurs with an accompanying change in vaginal pH (Fredricks et al., 2005) . Antimicrobial compounds produced by Lactobacillus spp. suppress the growth of opportunistic pathogens, maintain a normal vaginal flora and protect against ascending genital tract infections in healthy women (Dover et al., 2008; Rose et al., 2012; Sobel, 2000; Witkin et al., 2007) . In pregnant women, BV has been associated with early miscarriage, recurrent abortion, pre-term rupture of membranes, preterm birth and chorioamnionitis (Lamont et al., 2011) . Therefore, a reliable and accurate diagnosis is important if preventing these complications is to be achieved.
Whilst BV can account for abnormal discharge in the reproductive years between the ages of 15 and 44 years (http://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm), around 50 % of BV patients are asymptomatic and therefore diagnosis is reliant on laboratory techniques (Begum et al., 2010) . G. vaginalis decolourizes easily when using a crystal violet stain (Harper and Davis, 1982) , making Gram staining useful for its detection (Nugent et al., 1991) . The Gram stain-based Nugent score (Nugent score) is regarded as the 'gold standard' detection method for BV. Despite the potential for operator subjectivity in the estimation of different bacterial morphotypes (Nugent et al., 1991) it reliably categorizes women as with or without BV. However, a significant proportion of women have a micro-flora that is suggestive of neither BV nor a normal flora and is therefore categorized as 'intermediate'. Whilst clue cells (epithelial cells demonstrating a studded appearance due to the attachment of large numbers of G. vaginalis) aid in the diagnosis of BV, their absence in women with an intermediate flora decreases the specificity and positive predictive value of the Nugent score (Amsel et al., 1983; Nugent et al., 1991) . Microscopy also lacks sensitivity compared with molecular techniques (Kubista et al., 2006; Smith et al., 2003; Srinivasan et al., 2013) , and is further compromised when the Gram stain's reliability is reduced in the presence of antibiotics or when BV is associated with an increased composition of bacterial species such as Mycoplasma and Ureaplasma, which lack a defined cell wall (Rosenstein et al., 1996; Sha et al., 2005) . G. vaginalis load clearly increases in women with BV (Balashov et al., 2014) , suggesting that quantification would be useful in the diagnosis of this condition.
Investigation of G. vaginalis load in women with positive, negative and intermediate Nugent scores could facilitate a more reliable approach to BV diagnosis by defining an optimal load threshold and enabling a strategy for the reclassification of intermediate flora to a normal or abnormal state. The present study was performed to assess the analytical and clinical performance of a newly developed real-time quantitative PCR (qPCR) assay for the detection and quantification of G. vaginalis, and its comparison against respective Nugent scores to elucidate its potential use for predicting BV in a clinical setting using a quantitative threshold and for reclassifying women with an intermediate flora.
METHODS
G. vaginalis qPCR primer and probe design. The freeware primer design tool Primer3 (http://www.SimGene.com) was used for primer and probe design. The target region selected was a conserved region of the G. vaginalis 16S rRNA gene encoding a region previously identified and used to develop a SYBR Green assay published by ZozayaHinchliffe et al. (2010) . See Table 1 .
G. vaginalis qPCR TaqMan assay. All G. vaginalis qPCR assays in the study were carried out using the following reaction mix composition: 1| Platinum Quantitative PCR SuperMix-UDG (Life Technologies), and final working concentrations of reagents of 0.4 mM forward and reverse primer, 0.1 mM TaqMan probe, 0.2 mg BSA (Thermo Scientific) ml 21 and 4 mM MgCl 2 (Life Technologies). Final reaction volumes of 10 ml comprising 2 ml nucleic acid extract and 8 ml G. vaginalis reaction mix were used. All qPCR thermal cycling reactions were performed using a LightCycler 480 (Roche Diagnostics) with the following cycling conditions: 95 uC for 5 min, and 45 cycles of 95 uC for 15 s and 59 uC for 45 s. Samples that failed to produce an amplification curve after 45 cycles were recorded as negative.
Analytical specificity. Nucleic acid was extracted from a 200 ml suspension of each bacterial and fungal reference and clinical strain given in Table 2 using a MagNa Pure 96 automated extraction system (Roche Diagnostics). Nucleic acid extracts were tested using the G. vaginalis qPCR assay above.
G. vaginalis PCR quantification. Cloned DNA plasmids were utilized as standards for G. vaginalis PCR quantification and to determine the analytical limit of detection. G. vaginalis genomic DNA from type strain ATCC 49145D-5 (LGC Standards) was subjected to the G. vaginalis qPCR assay. The 121 bp G. vaginalis PCR amplicon was cloned using a TOPO TA Cloning kit (Invitrogen) in accordance with the manufacturer's instructions. Plasmid purification was performed using a QIAprep Miniprep kit (Qiagen) as described by the manufacturer. The DNA content from 1 ml plasmid mini prep was measured using a Nanodrop 2000 Spectrophotometer (Thermo Scientific) and the number of G. vaginalis genome copies ml 21 was calculated. Five replicates of G. vaginalis plasmid prep logarithmic dilutions in the range of 10
21 to 10 211 were tested against the G. vaginalis qPCR assay to determine the qPCR analytical sensitivity, linearity and efficiency. Each logarithmic dilution was input into the real-time PCR proprietary software as standard sample and corresponding genome copy number ml 21 for production of a standard curve.
G. vaginalis qPCR reproducibility. The coefficient of variation (CV; %) was calculated to assess the intra-and inter-assay variation. Five replicates of G. vaginalis plasmid over eight logarithmic dilutions were tested against two separately composed G. vaginalis qPCR mixes and tested using two different PCR runs to determine assay repeatability and run-to-run variation.
Clinical samples. Vaginal swabs from anonymized women submitted for Chlamydia trachomatis/Neisseria gonorrhoeae qPCR, with a concurrent vaginal swab submitted for diagnosis of BV by Nugent score (Nugent et al., 1991) as part of a routine genitourinary medicine screening, were used for assay validation. The age (in years) of each patient was recorded to enable further stratification of results; however, due to the nature of the study relying on anonymized residual material, a detailed clinical data set could not be included in the study.
Molecular testing. Nucleic acid extracts from a collection of residual vaginal swabs consisting of lower and higher vaginal swabs and endocervical swab types were collected after a routine Cobas 4800 Chlamydia trachomatis/Neisseria gonorrhoeae extraction and testing process and analysed with the G. vaginalis qPCR assay. The presence and quantity (copies ml 21 ) of G. vaginalis were recorded. As a measure of specimen quality, all swabs were additionally analysed with a human RNase P TaqMan assay (WHO, 2009 ). An RNase P cycle threshold (C T ) value of j30 was regarded as valid.
Gram stain Nugent score criteria. A separate vaginal swab was smeared onto a glass slide, heat fixed and Gram stained. Grampositive, Gram-negative or Gram-variable bacterial morphotypes were quantified in accordance with the Nugent score technique (Nugent et al., 1991) . Women were categorized as non-BV (Nugent score 0-3), intermediate or BV (Nugent score i7).
Statistical analysis. Mean G. vaginalis load was calculated for women with BV, intermediate and non-BV Nugent scores. Mean loads were log 10 transformed to fit a normal distribution, and comparisons of mean load between the three groups of women were performed using a one-way ANOVA test. A preliminary load threshold was adjusted and compared against respective Nugent score results. The same load threshold was adjusted to potentially recategorize intermediate samples as BV or normal with regard to G. vaginalis load. A P value of j0.05 was regarded as significant. 
RESULTS

Primer and probe selection
The G. vaginalis primer and probe sequences and properties are outlined in Table 1 . Forward and reverse primers targeting a 121 bp region of the G. vaginalis 16S rRNA gene were selected. A probe sequence complementary to a 20 bp region between the forward and reverse primerbinding sites was also selected. The probe 59 end was labelled with the fluorescent reporter 6-carboxyfluorescein and the 39 end labelled with Black Hole Quencher dye to enable qPCR performance using TaqMan thermal cycling.
Analytical specificity
Nucleic acid extracts from a total of 39 different clinical and reference microbial strains were used to determine analytical specificity of the G. vaginalis qPCR assay. The qPCR assay successfully amplified G. vaginalis ATCC 49145 type strain DNA and did not cross-react with any other organism DNA on the specificity panel; therefore the qPCR assay was 100 % specific for G. vaginalis. The specificity results are summarized in Table 2 .
Analytical sensitivity, linearity and efficiency
A correlation co-efficient greater than 0.99 was calculated when log 10 DNA concentration was plotted against C T values of logarithmic serial dilutions, demonstrating excellent linearity as outlined in Fig. 1 . The PCR amplification efficiency (10 21/slope 21) was 100 % (slope523.32), which indicated doubling of the template after each cycle. The G. vaginalis qPCR was capable of detecting 6.2 gene copies per reaction and reproducibly detected 62 gene copies per reaction (equating to 3.1|10 4 gene copies ml 21 ).
Assay reproducibility
Respective highest and lowest CVs of 1 and 0.27 % were calculated within PCR runs, suggesting minimal scatter between replicates. Thus, high intra-assay precision runto-run variation was also minimal with calculated CVs of less than 4.5 % for comparison between runs. Lowest and highest CVs for inter-assay variation were 2.1 and 4.3 %, respectively. . Loads were log 10 transformed to fit a normal distribution and compared using a one-way ANOVA test. A significant P value of v0.001 was calculated for the comparisons of G. vaginalis mean load between the three groups of women. In BV women, a minimum G. vaginalis load of 1.0|10 7 gene copies ml 21 was detected, whereas in intermediate and non-BV women, minimum loads were 61 and 770 gene copies ml
21
, respectively. Comparisons of mean load between the three groups of women are outlined in Table 3 . A preliminary quantitative threshold of i10 7 gene copies ml 21 generated 30 (20.8 %) false positives, 114 (79.2 %) true negatives, 40 (100 %) true positives and zero false negatives when compared directly Among these women, 14 (58.3 %) had a G. vaginalis load of i10 7 gene copies ml 21 consistent with the minimum load detected in women with BV, whereas the remaining 10 (41.7 %) women were G. vaginalis negative or had a load of v10 7 gene copies ml
. The mean Nugent scores of women with loads consistent with BV and non-BV were 5 and 4.1, respectively.
DISCUSSION
Among all the women in the study, 11.5 % had an uncharacterized intermediate flora, which makes a decision to treat difficult (Menard et al., 2008) . The rate (58.3 %) of intermediate women reclassified as BV by the arbitrary use of a 10 7 threshold was comparable to the rate reported in a previous study (57 %), which predicted BV by quantifying G. vaginalis and Atopobium vaginae (Menard et al., 2008 (Menard et al., , 2010 (Menard et al., , 2012 .
Whilst the current Nugent score technique readily distinguishes between women with and without BV, the subjective nature of microscopy forces it to use a categorical reporting method that leaves a significant number of women unclassified. A proportion of women with BV may be misdiagnosed and others left undefined, with an intermediate flora that is neither normal nor in keeping with BV (Menard et al., 2010) ; therefore, a better 'gold standard' needs to be defined (Menard et al., 2008) . Previous studies have focused on using molecular methods to detect bacteria associated with BV (Menard et al., 2008; Zozaya-Hinchliffe et al., 2010) ; however, to the best of our knowledge, there are no publications that report the single detection of G. vaginalis for the molecular prediction of BV.
The newly described G. vaginalis qPCR assay targeted the 16S rRNA gene. The increased specificity, quantitative accuracy and speed of TaqMan protocols provide the optimal characteristics for a suitable assay (Espy et al., 2006; Ginzinger, 2002; Kubista et al., 2006; Mackay, 2004) . Whilst keeping the original target region used by ZozayaHinchliffe et al. (2010) , the forward and reverse primer sequences were modified and a TaqMan probe replaced the dependence on SYBR Green.
Analytical validation of the G. vaginalis qPCR assay was carried out in line with the Minimum Information for Publication of Quantitative real-time PCR Experiments (MIQE) Guidelines (Bustin et al., 2009) and confirmed that the assay performed with high analytical sensitivity and specificity. Alignment of the primer and probe sequences showed no homology with any other organism in GenBank, and this was supported by testing against a panel of 40 nucleic acid extracts derived from a variety of reference and clinical bacterial and fungal isolates. The qPCR assay had good reproducibility and demonstrated reliable detection of 62 gene copies per reaction (equating to 3.1|10 4 gene copies ml 21 ). This level of sensitivity would be suited for use in BV diagnosis.
Performance against a current 'gold standard' is the norm in the evaluation of a new diagnostic test (Public Health England, 2014) . The lower specificity against BV determination by microscopy is characteristic where a molecular to a non-molecular comparison is undertaken, but otherwise the qPCR assay performed as expected (Cartwright et al., 2012; Kobayashi et al., 2006; Kubista et al., 2006; Nathan et al., 2015; Whiley et al., 2006) . As the qPCR assay showed no sequence overlap or cross-reactivity with sequence alignment and panel tests, the additional qPCR results are real but lack an established reference threshold value for confirmation of BV.
The lack of a reference qPCR threshold and the indeterminate intermediate range of the Nugent score make it impossible to undertake a fully meaningful head-to-head comparison and clearly indicate the need for better discrimination in establishing a diagnosis of BV (Smith et al., 2003; Srinivasan et al., 2013) . All BV-confirmed samples in the study had a minimal G. vaginalis load of 10 7 copies ml
21
, and this threshold when arbitrarily used for prediction of BV against Nugent scores had a negative predictive value of 100 %. However, the overlap of G. vaginalis loads in non-BV and intermediate scores indicates the need for an alternative technique to assess discordant results; ultimately, a comparison against the vaginal microbiome could provide such a measure.
BV had a higher mean G. vaginalis load (1.06|10 9 copies ml 21 ) than where an intermediate score was returned (3.21|10 8 copies ml
) and similarly non-BV scores returned the lowest loads (1.1|10 8 gene copies ml
), confirming the association of G. vaginalis loads with BV. A significant increasing trend in G. vaginalis prevalence (P57.3|10
26
) with a significant difference in load (P55.1|10
214
) among the three groups of women also suggested the potential for establishing a threshold load to distinguish BV from non-BV. If established, the use of qPCR for defining/excluding BV would also help support the development of a syndromic molecular sexually transmitted infection screen covering G. vaginalis, N. gonorrhoeae, C. trachomatis and Trichomonas vaginalis, reflective of conditions that present with an overlap of clinical presentation (Benzaken et al., 2006; Romoren et al., 2007; Sivaranjini et al., 2013; Willett and Centor, 2005) .
Whilst the current results are promising, they indicate the need for further validation and standardization of the G. vaginalis qPCR or similar assays. Comparison against vaginal microbiomes across the range of Nugent scores would be the most logical comparison against which to achieve this goal. 
